{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:18:19Z","timestamp":1747178299189,"version":"3.40.5"},"reference-count":10,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.1080\/1120009x.2023.2266201","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:28:20Z","timestamp":1696595300000},"page":"198-201","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Varicella zoster virus reactivation reported with isatuximab use"],"prefix":"10.1080","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2620-1885","authenticated-orcid":false,"given":"Michelle","family":"Nadeau Nguyen","sequence":"first","affiliation":[{"name":"Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3985-2935","authenticated-orcid":false,"given":"Gra\u00e7a M.","family":"Dores","sequence":"additional","affiliation":[{"name":"Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afrouz","family":"Nayernama","sequence":"additional","affiliation":[{"name":"Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Christopher","family":"Jones","sequence":"additional","affiliation":[{"name":"Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2015.1083858"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.02.002"},{"key":"e_1_3_2_4_1","unstructured":"Sarclisa (isatuximab) [package insert]. Bridgewater (NJ): Sanofi Aventis US; 2022."},{"key":"e_1_3_2_5_1","unstructured":"US Food and Drug Administration. Questions and Answers on FDA's Adverse Event Reporting System. https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers. Accessed June 30 2023."},{"key":"e_1_3_2_6_1","unstructured":"WHO-UMC system for standardization case causality assessment. Accessed on May 5 2023 at https:\/\/who-umc.org\/media\/164200\/who-umc-causality-assessment_new-logo.pdf"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32556-5"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00592-4"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac574"},{"key":"e_1_3_2_10_1","unstructured":"Darzalex (daratumumab) [package insert]. Horsham (PA): Janssen Biotech Inc.; 2021."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010228"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1120009X.2023.2266201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:32:36Z","timestamp":1727188356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1120009X.2023.2266201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4,2]]}},"alternative-id":["10.1080\/1120009X.2023.2266201"],"URL":"https:\/\/doi.org\/10.1080\/1120009x.2023.2266201","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"type":"print","value":"1120-009X"},{"type":"electronic","value":"1973-9478"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yjoc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yjoc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}